Adbry shortage status
1 active shortage notice across 1 country.
Last updated 1 Aug 2026 · sourced from official medicines regulators
- Generic name (INN)
- Adbry
- ATC code
- D11AH07
- Class
- Auto-created by FDA MedWatch — Drug Safety Alerts scraper
Where Adbry is in shortage
| Country | Severity | Notices | Since | Est. resolution | Source |
|---|---|---|---|---|---|
| United States | high | 1 | 10 Feb 2026 | — | FDA MedWatch |
Why Adbry is in shortage
- regulatory action — e.g. “Lack of Assurance of Sterility: due to the presence of particulate matter in one unit from the lot, which lab tests have identified as wool fiber.” (United States)
Frequently asked questions
Is Adbry currently in shortage?
Yes. As of the latest regulator updates, Adbry has 1 active shortage notice across 1 country (United States). Status is refreshed daily from official regulatory sources.
Why is Adbry in shortage?
Regulators attribute the current Adbry shortages to regulatory action. The exact cause varies by country and product — each notice on this page links to the official source.
Where does this Adbry shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.
Related medicines
Diclofenac-Potassium · Caffeine · Brimonidina · Finasteride · Tacrolimus-Monohydrate · Abrocitinib
Get alerted when Adbry status changes
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Create a free accountData on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.